Todas las investigaciones
ReclutamientoFarmacología Humana (Fase I) - OtrosIntervencionista

A study in subjects with gout flares that investigates the effect, safety, tolerability, and pharmacokinetics (absorption, distribution, metabolism, and elimination) of a single dose of LEO 158968, a new compound that may potentially be used in the treatment of several autoinflammatory diseases

This research study is for men aged 18 and over who are experiencing gout flares. It's investigating a new medicine called LEO 158968. Researchers want to understand several things: how safe the medicine is, if people can tolerate it well, and how the body absorbs and processes it. This is an early-stage study, meaning it's one of the first times this new medicine is being given to people. The main goal is to see if LEO 158968 could potentially be a treatment for gout flares and similar conditions in the future by testing a single dose. Participants will help researchers learn important information about this new drug.

De un vistazo

Estado
Reclutamiento
Fase
Farmacología Humana (Fase I) - Otros
Patrocinador
Leo Pharma A/S
Objetivo de inscripción
13
Inicio
10 Sep 2024

¿De qué trata este estudio?

This study is exploring a new medicine, called LEO 158968, that might one day help people with painful gout flares. Gout flares happen when a substance called uric acid builds up in your body, forming crystals in your joints. This can cause sudden, severe pain, swelling, and redness.

Researchers want to understand how this new medicine works in the body. They'll be looking carefully at how safe it is, whether people have any side effects, and how the body takes in, uses, and gets rid of the medicine. This is an important first step to see if this new medicine could be a good treatment option in the future, not just for gout but possibly for other conditions where the body's immune system mistakenly attacks itself.

Because this is a very early study, called a Phase I study, it means the medicine is new and hasn't been widely tested in people before. The study will involve giving participants a single dose of LEO 158968. The information gathered will be crucial for deciding if this medicine should be studied further.

Puntos clave

  • This study is testing a new medicine for gout flares.
  • It's an early-stage study focused on safety and how the body handles the medicine.
  • Only men aged 18 and over, currently experiencing a gout flare, can participate.
  • Participants will receive a single dose of the new medicine.
  • Your health will be closely monitored throughout the study.

¿Quién puede ser elegible?

This study is specifically looking for male volunteers who are at least 18 years old. There is no upper age limit for participating, as long as you meet the other requirements. Participants must be experiencing a gout flare when they join the study.

Other health conditions or medicines you are currently taking might mean you cannot take part. This is to ensure the safety of everyone in the study and to make sure the results are clear. The research team will carefully review your health information to see if this study is suitable for you.

It's important to discuss any health concerns with the study doctor during the screening process. They will explain all the requirements in detail and help you understand if you can join.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Eres hombre?
  2. ¿Tienes 18 años o más?
  3. Are you currently having a gout flare?
  4. Are you generally able to attend study visits?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you decide to take part, you'll first have screening visits to check if you're suitable for the study. This will likely involve health checks, blood tests, and reviewing your medical history. Once confirmed, you will receive a single dose of the study medicine, LEO 158968. You will be closely monitored by the study team for a period after receiving this dose to check for any immediate effects.

There will be follow-up visits or phone calls to see how you are feeling and to collect more information about the medicine's effects and how your body is handling it. These visits will involve further health checks and possibly more blood tests. The total duration of your participation in the study, from first screening to final follow-up, will be explained fully by the research team.

Riesgos y beneficios potenciales

Taking part in this study could potentially help advance medical knowledge about new treatments for gout and similar conditions, which might benefit others in the future. However, as with any new medicine, there might be unknown side effects or risks. You will be closely monitored for your safety. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Ubicaciones (2)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Países Bajos
  • —
    No verificado
    Francia

Preguntas comunes

What is a 'gout flare'?

A gout flare is a sudden, very painful attack of arthritis, often in the big toe, caused by a buildup of uric acid crystals in a joint.

What does 'early-stage study' mean?

It means this is one of the first times this new medicine is being tested in people to check its safety and how it works in the body.

Will I get better from my gout by being in this study?

The main goal of this study is to gather information about the new medicine. While it might help, there's no guarantee the medicine will improve your gout.

Why is it only for men?

Early studies sometimes focus on one gender to simplify the initial testing. If the medicine proves safe, it may be tested in women in later studies.

¿Tendré que pagar para participar en el estudio?

No, you will not have to pay for any study-related procedures or the medicine. Sometimes, travel expenses may be covered.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "A study in subjects with gout flares that investigates the e…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.